Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,646 total articles
SkyWest Inc. Chief Commercial Officer Wade J. Steel disposed of 20,629 shares on February 24, 2026, receiving roughly $2.2 million. The transaction occurred at a weighted average price of $106.5281. The company recently reported fourth-quarter 2025 results that topped analyst forecasts, while InvestingPro analysis notes the stock is overvalued vers…
Director Jack Bendheim and BFI Co., LLC, a ten percent owner of Phibro Animal Health Corp (NASDAQ: PAHC), sold a combined $1.1 million in Class A common stock between February 24 and February 26, 2026. The disposition comprised 20,120 shares executed under a Rule 10b5-1 trading plan adopted May 30, 2025. The stock is trading near its 52-week high, …
BlackRock Senior Managing Director J. Richard Kushel sold 2,385 shares of BlackRock stock on February 24, 2026, in two transactions that generated $2.58 million in proceeds. The trades were executed at prices between $1,083.05 and $1,084.9101 per share. After the sales, Kushel retains both direct and indirect holdings in the company. The transactio…
Ourania Tatsis, Executive Vice President at Vertex Pharmaceuticals, sold shares under a pre-established Rule 10b5-1 trading plan, disposing of 1,887 shares across two days for roughly $915,724. The trades were filed on a Form 4 with the SEC. Vertex shares trade near their 52-week high even as the company reported a slight EPS miss for Q4 2025 and a…
Amit Sachdev, Vertex Pharmaceuticals' Executive Vice President and Chief Patient & External Affairs Officer, executed two share dispositions across February 24-25, 2026, via a company-approved 10b5-1 trading plan. The transactions reduced his directly held stake while leaving him with substantial direct and indirect holdings. The stock sales oc…
Krystal Biotech director Daniel Janney sold 37,825 shares of common stock on February 24, 2026, generating $10,113,353 in proceeds, and also sold 13,666 shares indirectly owned by Alta Bioequities, L.P. for $6,036,029. Janney simultaneously exercised options to acquire 37,895 shares at $2.46 per share under a Rule 10b5-1 trading plan.
Duncan McKechnie, Vertex Pharmaceuticals' Executive Vice President and Chief Commercial Officer, sold a total of 5,783 shares across February 24-25, 2026, generating roughly $2.81 million in proceeds. The transactions were executed under a 10b5-1 plan and reported via a Form 4 filing. The trade comes while Vertex shares trade near their 52-week hig…
Aftab Dana, Executive Vice President for Research and Development at Exelixis, Inc. (NASDAQ: EXEL), sold 47,918 shares on February 24, 2026, for $44.50 per share, totaling $2,132,351. The transaction occurs while third-party analysis flags the stock as trading below its intrinsic value. Exelixis reported a fourth-quarter 2025 EPS beat but missed re…
Mueller Water Products director Gregg C Sengstack bought 25,000 shares on February 25, 2026, in a transaction valued at $739,415. The purchase occurred as the shares trade close to a 52-week high and follows quarterly results that exceeded analyst forecasts on both earnings per share and revenue. Market valuation metrics from InvestingPro flag the …
Meta Platforms Chief Financial Officer Susan J. Li, via a trust, disposed of 58,478 shares of Class A common stock on February 24, 2026, in transactions totaling roughly $35.3 million. The sales were part of a Rule 10b5-1 plan adopted in November 2025. The filing outlines the trust's remaining indirect holdings and notes related corporateoperationa…
Comfort Systems USA INC (NYSE:FIX) said its president and CEO, Brian E. Lane, sold 9,365 shares on February 25, 2026, in a transaction valued at $13.6 million. The move follows an exceptional stock performance over the past year and a quarter that materially exceeded expectations. The company also reported strong fourth-quarter 2025 results and rec…
Todd M. Cleveland, a director at IES Holdings, Inc. (NASDAQ: IESC), sold 4,896 shares of common stock between February 24 and February 26, 2026, for roughly $2.5 million. The trades came while the stock trades at $515.05, up 177% over the prior year; recent company results showed a revenue beat but an earnings miss for the first quarter of fiscal 2…
iRhythm Holdings' Chief Medical Officer, Minang Turakhia, sold 7,804 shares on February 25, 2026, for roughly $1.05 million, following a week in which the stock fell 11.8% before partial recovery. The filing also shows Turakhia received 15,060 shares the day prior upon vesting of performance RSUs. The company reported robust fourth-quarter results,…
iRhythm Holdings Executive Vice President Mervin Smith sold 4,041 shares on February 25, 2026, for $547,227 after vesting of performance-based restricted stock units the prior day. The transaction follows strong quarterly results from iRhythm, including a revenue beat and the company’s first positive GAAP net income, while analysts adjusted price t…
Ernest S. Rady, Executive Chairman of American Assets Trust, made two purchases of the company’s common stock on February 25 and 26, 2026, totaling $212,582. The acquisitions raised his indirect holdings to 8,114,565 shares held by the Ernest Rady Trust. The transactions occurred amid a quarter that delivered revenue above expectations but earnings…
Jennifer Fremont Simons, Oceaneering’s senior vice president, chief legal officer and secretary, sold 10,284 shares on Feb. 25, 2026 for roughly $400,664 while also disposing of 6,673 shares on Feb. 24, 2026 to cover taxes. The stock trades near a 52-week high after a 70% year-over-year rise; InvestingPro’s analysis indicates shares are above its F…
Engine Capital Management and related entities acquired $1.73 million of Orthofix Medical Inc. shares on February 24-25, 2026, purchasing at prices between $12.5455 and $12.9634 per share. The transactions increased the Engine-affiliated group’s direct holdings to a position that may exceed 10% of the company’s outstanding common stock. Orthofix is…
iRhythm Holdings Inc (IRTC) Chief Accounting Officer Marc Wade Rosenbaum sold 4,797 shares on Feb. 25, 2026 for about $649,604 after receiving 9,210 shares from RSU vesting a day earlier. The transactions leave him with 15,014 shares. The company reported robust fourth-quarter revenue and its first positive GAAP net income, while some analysts trim…
Oceaneering International (OII) Senior Vice President and Chief Human Resources Officer Holly Kriendler sold 24,805 shares of common stock in late February, generating roughly $933,457, according to a Form 4 filed with the SEC. The insider transactions occurred on February 24, 25 and 26 at prices between $37.22 and $37.955. After the sales, Kriendl…
Bloom Barry A N, President and Chief Operating Officer of Xenia Hotels & Resorts, Inc. (NYSE: XHR), sold 202,508 shares of common stock on February 25 and 26, 2026, totaling roughly $3.17 million. The transactions followed an acquisition of 27,534 LTIP Units on February 24. Xenia also posted fourth-quarter 2025 results that beat consensus on both E…
Ashley W. Hanscom, Principal Accounting Officer of THE CHEESECAKE FACTORY INC (NASDAQ:CAKE), sold 2,951 shares on February 25, 2026 for $193,688, according to a Form 4 filing. The transaction occurs as the stock trades near $65 with a market capitalization of $3.24 billion and a notable 30.6% year-to-date gain. The company posted modest beats on re…
Ryder System President and COO John J. Diez completed a series of equity transactions on February 25, 2026, including the sale of 9,632 shares for $2.14 million and the exercise of stock options that led to further dispositions to cover taxes. The moves coincide with recent quarterly results that showed an EPS beat but a slight revenue shortfall, a…
A company director sold 200 shares of American Superconductor Corporation (AMSC) on February 24, 2026, in a transaction disclosed on an SEC Form 4. The sale occurred at $34.10 per share for a total of $6,820. The transaction comes as the stock trades below its 52-week peak and after the company reported a sizable third-quarter earnings beat for fis…
Alexander P. Scarpelli, Senior Vice President, Corporate Controller and Chief Accounting Officer of Regal Rexnord CORP (NASDAQ: RRX), sold 290 shares of company stock on February 25, 2026, receiving $64,887 at a weighted average price of $223.75 per share. Scarpelli continues to hold 3,470.401 shares directly and maintains Stock Appreciation Rights…
Regal Rexnord Corp. Executive Vice President and CFO Robert Rehard sold a total of 2,257 shares of common stock on February 24 and 25, 2026, for roughly $503,478. The transactions, executed at prices between $223.00 and $223.13, occurred while the shares were trading close to a 52-week high of $229.30 after a 66% one-year advance. Post-sale, Rehard…
